Top 50 Health Care VC Funds & Investors in Ireland (May 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Enterprise Ireland
VC Fund
|
62 | Ireland, United States, United Kingdom | Seed, Series A | Software, Health Care, Information Technology | $429k–$12M |
|
Kernel Capital
VC Fund
|
15 | Ireland, United Kingdom, France | Seed, Series A | Software, Information Technology, Health Care | $536k–$9M |
|
AIB Seed Capital Fund
VC Fund
|
14 | Ireland, United States, Jersey | Seed, Series A | Software, Health Care, Medical | $536k–$6.4M |
|
Western Development Commission
VC Fund
|
13 | Ireland, United States | Seed, Series A | Medical Device, Health Care, Medical | $696k–$8M |
|
Atlantic Bridge University Fund
VC Fund
|
12 | Ireland, United States | Seed, Series A | Medical Device, Health Care, Big Data | $804k–$12M |
|
NDRC
VC Fund
|
10 | Ireland, United States, United Kingdom | Seed, Pre-Seed, Convertible Note | Software, Information Technology, E-Commerce | $21k–$1.1M |
|
Enterprise Equity
VC Fund
|
10 | Ireland, United States, United Kingdom | Seed, Series B | Software, Information Technology, Medical Device | $536k–$7.5M |
|
Act Venture Capital
VC Fund
|
9 | Ireland, United States, United Kingdom | Seed, Series A | Software, Information Technology, Analytics | $804k–$13M |
|
Irrus Investments
VC Fund
|
9 | Ireland, Sweden, United States | Seed, Series A | Biotechnology, Health Care, Medical Device | $696k–$3.8M |
|
Fountain Healthcare Partners
VC Fund
|
8 | Ireland, United States, France | Series A, Series B, Series C | Health Care, Biotechnology, Medical | $3.2M–$55M |
|
Elkstone Capital Partners
VC Fund
|
8 | Ireland, United Kingdom, United States | Seed, Series A | Software, Medical, Medical Device | $536k–$12M |
|
Delta Partners
VC Fund
|
7 | Ireland, United States, United Kingdom | Seed, Series A | Software, Information Technology, Health Care | $777k–$6.4M |
|
EIT Health
VC Fund
|
7 | United Kingdom, Spain, Ireland | Grant, Pre-Seed, Seed | Health Care, Medical Device, Medical | $21k–$1.4M |
|
Seroba Life Sciences
VC Fund
|
7 | Ireland, United States, United Kingdom | Series A, Series B | Health Care, Biotechnology, Medical | $1.2M–$37M |
|
Business Venture Partners
VC Fund
|
6 | Ireland, Luxembourg, The Netherlands | Seed, Series A | Health Care, Information Technology, Software | $375k–$12M |
|
Xenium Capital
VC Fund
|
4 | Ireland | Seed | Medical Device, Health Care, Biotechnology | |
|
HBAN Medtech Syndicate
VC Fund
|
4 | Ireland | Seed, Series B | Medical Device, Medical, Health Care | |
|
Boole
VC Fund
|
4 | Ireland | Seed | Medical Device, Health Care, Medical | |
|
Atlantic Bridge
VC Fund
|
4 | United States, Ireland, United Kingdom | Series A, Series B | Software, Information Technology, Artificial Intelligence | $2.5M–$25M |
|
The Yield Lab Europe
VC Fund
|
4 | Ireland, United Kingdom, France | Seed, Series A | AgTech, Agriculture, Biotechnology | $536k–$10M |
|
European Investment Bank
VC Fund
|
3 | France, Germany, Ireland | Debt Financing, Post-IPO Debt | Biotechnology, Health Care, Software | $6.4M–$536M |
|
EQT life science
VC Fund
|
3 | United States, The Netherlands, Switzerland | Series A, Series B, Series C | Biotechnology, Health Care, Therapeutics | $5.4M–$70M |
|
Furthr VC
VC Fund
|
3 | Ireland | Seed, Pre-Seed | Medical, Medical Device, Health Care | $857k–$3.9M |
|
Broadview Ventures
VC Fund
|
3 | United States, Israel, Denmark | Series A, Seed, Debt Financing | Health Care, Biotechnology, Medical Device | $750k–$11M |
|
Medtech Syndicate Nominee
VC Fund
|
3 | Ireland | Seed, Series A | Medical, Health Care, Medical Device | |
|
Business Growth Fund
VC Fund
|
3 | United Kingdom, Ireland, United States | Series A, Private Equity | Software, Information Technology, Manufacturing | $1.2M–$28M |
|
Venturewave Capital
VC Fund
|
3 | Ireland | Series A | Health Care, Apps, Education | |
|
Lightstone Ventures
VC Fund
|
3 | United States, Ireland, Singapore | Series B, Series A, Series C | Biotechnology, Health Care, Therapeutics | $5M–$95M |
|
Development Capital
VC Fund
|
3 | Ireland, United States, United Kingdom | Seed | Manufacturing, Software, Health Care | |
|
Earlybird Venture Capital
VC Fund
|
2 | Germany, United States, United Kingdom | Series A, Seed, Series B | Software, Information Technology, Health Care | $1.2M–$40M |
|
HealthCap
VC Fund
|
2 | United States, Sweden, France | Series B, Series A | Biotechnology, Health Care, Medical | $5.5M–$55M |
|
Cantor Fitzgerald
VC Fund
|
2 | United States, Canada, Ireland | Post-IPO Equity, Series B, Series A | Biotechnology, Health Care, Medical | $6.4M–$250M |
|
SVG Ventures
VC Fund
|
2 | United States, Canada, Ireland | Pre-Seed, Seed | AgTech, Agriculture, Farming | $75k–$6.3M |
|
Infinity Capital
VC Fund
|
2 | United States, Ireland, Canada | Series B, Series D | Semiconductor, E-Commerce, Electronics | $4M–$50M |
|
Mayo Clinic Ventures
VC Fund
|
2 | United States, Ireland, China | Series A, Series B, Seed | Health Care, Biotechnology, Medical | $1.4M–$69M |
|
Oyster Capital Partners
VC Fund
|
2 | Ireland, United Kingdom, United States | Series A, Seed | Software, Medical Device, Enterprise Software | $4M–$12M |
|
Ascentifi
VC Fund
|
2 | Ireland | Series A | Medical Device, Medical, Hospital | |
|
E15 VC
VC Fund
|
2 | United States, Ireland | Seed, Series A, Pre-Seed | Health Care, Medical, Robotics | $1.3M–$5M |
|
Glanzmann Enterprises
VC Fund
|
2 | Ireland | Series A | Medical, Health Care, Medical Device | |
|
Greycroft
VC Fund
|
1 | United States, United Kingdom, Germany | Series A, Seed, Series B | Software, E-Commerce, Internet | $1.5M–$45M |
| Dublin Business Innovation Centre | 1 | Software, Internet, Data and Analytics | |||
|
Cell Capital
VC Fund
|
1 | United Kingdom, Ireland, United States | Seed | Internet of Things, Software, Information Technology | |
| Acorn Bioventures | 1 | Post-IPO Equity | Health Care, Biotechnology, Science/Engineering | $14M–$155M | |
| Zoosh Group | 1 | Pre-Seed, Seed | Software, IT, Data and Analytics | ||
|
DHKN
VC Fund
|
1 | Ireland | Medical, Health Care, Medical Device | ||
|
Moffett Investment Holdings
VC Fund
|
1 | Ireland | Series A, Series B | Medical, Health Care, Biotechnology | |
|
The University of Vermont Health Network
VC Fund
|
1 | United States, Ireland | Seed, Series B | Medical, Biotechnology, Fashion | |
|
Gaingels
VC Fund
|
1 | United States, Canada, Germany | Seed, Series A, Series B | Software, Health Care, FinTech | $1.2M–$70M |
|
Gilde Healthcare
VC Fund
|
1 | United States, The Netherlands, Germany | Series C, Series B, Series A | Biotechnology, Health Care, Medical | $8M–$60M |
|
Wellcome Trust
VC Fund
|
1 | United States, United Kingdom, Germany | Grant, Series C | Biotechnology, Health Care, Pharmaceutical | $1.2M–$90M |
| Access all 182 VC funds in Ireland Health Care startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Enterprise Ireland is the government agency responsible for the development and funding of the indigenous business sector. Their mission is to accelerate the development of companies to achieve strong positions in global markets resulting in increased national and regional prosperity. It was founded in 1998 and headquartered in Dublin, Ireland.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Seed, Series A
- Geography: Ireland, United States, United Kingdom
Investor stats
- Total investments: 383
- Round size: Seed $429k–$2.9M; Series A $2M–$12M
- Lead/follow: 15% lead, 85% follow
- Last fund: May invest from a new fund soon — raised $1.1M in 2021
Portfolio highlights
- CergenX — CergenX produces cutting-edge technology for the analysis of baby brain waves that can be used to identify brain injuries early in the newborn period.
- Tailr — Redefining production for the clothing industry.
- Recruitroo — Recruitroo is a international recruitment agency that uses technologies to streamline and improve the international recruitment process for both companies and candidates.
Kernel Capital is the independent manager of The Bank of Ireland Kernel Capital Venture Funds, one of the largest and most active sources of equity finance on the island of Ireland. Kernel leverage their extensive network to enable their portfolio companies recruit the highest caliber people, to break into new international markets and to generaterevenues of scale. It is the only investment firm with venture capital Funds dedicated to both jurisdictions on the Island. Kernel have raised over €210M from investors which including their strategic partner Bank of Ireland, Invest NI, Enterprise Ireland, Galway University Foundation, The University of Limerick Foundation, The New York State Common Retirement Fund and undisclosed Family Offices. Consistently delivering strong financial returns for their investors Kernel have led more than 20 substantial trade sales to NASDAQ, NYSE, and LSE listed corporations.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Series A
- Geography: Ireland, United Kingdom, France
Investor stats
- Total investments: 86
- Round size: Seed $536k–$4.3M; Series A $1.4M–$9M
- Lead/follow: 50% lead, 50% follow
- Last fund: May invest from a new fund soon — last raise in 2013
Portfolio highlights
- Pretto — Pretto is the only truly transparent online real estate price comparator.Pretto accompanies you until the signing of your loan, free of charge and without commitment.
- Pilot Photonics — Welcome to Pilot Photonics, a laser product development company in Dublin, Ireland. We provide optical frequency combs and tunable lasers.
- Causeway Sensors — The Affinity, is a compact, bench-top Biosensor providing accurate real-time analysis at an accessible price. The Affinity biosensor and accompanying Access Chip incorporate the latest advancements in Nanotechnology, providing the biochemistry researcher the perfect platform to explore the complex world of biomolecular interactions.
The AIB Seed Capital Fund was established in 2007 to provide venture capital for companies at the seed and early stages of development across a range of sectors throughout the Republic of Ireland. The Fund was established under the Enterprise Ireland Seed and Venture Capital Programme 2007-2012.The Fund has a total of €30m under managementwith AIB and Enterprise Ireland both committing €15m. It is managed by experienced managers with extensive expertise in making seed and early stage investments, adding value and facilitating business success.The Fund managers are empowered to make seed investments of up to approximately €500,000. Furthermore, the Fund has the capacity to make investments in later rounds to support the continued growth of investee companies.The Fund will be managed by Enterprise Equity Venture Capital and the Dublin Business Innovation Centre. This unique partnership brings together extensive regional and investment expertise.Enterprise Equity will evaluate and manage all investments outside the city and county of Dublin, as well as investments that require in excess of €250,000 from the fund within the city and county of Dublin.Dublin Business Innovation Centre (DBIC) will evaluate and manage all investments within the city and county of Dublin when the initial investment amount required from the Fund does not exceed €250,000.
Show more...Investment focus
- Industry: Software, Health Care, Medical
- Stage:Seed, Series A
- Geography: Ireland, United States, Jersey
Investor stats
- Total investments: 49
- Round size: Seed $536k–$3.2M; Series A $1.1M–$6.4M
- Lead/follow: 18% lead, 82% follow
Portfolio highlights
- NewsWhip — The only real-time media monitoring platform that predicts the stories and topics that will matter in the hours ahead.
- Offr — Offr is the new way to buy and sell property, quickly and transparently.
- Metabolomic Diagnostics — https://metabolomicdiagnostics.com/ A deep-tech company specialized in the development of biomarker-based diagnostic solutions
Supporting communities to grow, investing in businesses to scale and planning for the future of the western region.
Show more...Investment focus
- Industry: Medical Device, Health Care, Medical
- Stage:Seed, Series A
- Geography: Ireland, United States
Investor stats
- Total investments: 32
- Round size: Seed $696k–$3.8M; Series A $4.7M–$8M
- Lead/follow: 13% lead, 87% follow
Portfolio highlights
- ByoWave — ByoWave has developed the Proteus Controller, a modular, accessible video game controller for disabled and non-disabled gamers.
- Bluedrop Medical — Thermal and visual assessment in a single scan. Award winning, patented design.
- Amara Therapeutics — Amara Therapeutics is passionate about empowering women and men to take control of their pelvic health. Amara Therapeutics use evidence based medicine and behavioural interventions supported by Amara Therapeutics platform of technologies to provide safe, convenient and non-invasive care pathways. At Amara Therapeutics mission is to fix the carepathway for pelvic health patients, connecting healthcare providers, patients and peers through our platform.
We invest in entrepreneurs with the ambition to create world-class companies of scale.
Show more...Investment focus
- Industry: Medical Device, Health Care, Big Data
- Stage:Seed, Series A
- Geography: Ireland, United States
Investor stats
- Total investments: 28
- Round size: Seed $804k–$3.8M; Series A $3.1M–$12M
- Lead/follow: 64% lead, 36% follow
Portfolio highlights
- CroíValve — CroíValve is a developed a safe, effective, easy to use, percutaneous solution for treating all patients with severe Tricuspid Regurgitation
- ProVerum Medical — ProVerum Medical is an early stage medical device startup for the treatment of Benign Prostatic Hyperplasia (BPH).
- Tympany Medical — Tympany Medical is a Needs-driven, Innovative MedTech StartUp based in the West of Ireland
NDRC builds high-impact new ventures. By providing the people, time, space and investment needed at the earliest stages of dedicated commercialisation work, NDRC is creating companies worthy of commercial investment and with the ability to scale. The NDRC team has the breadth of knowledge and expertise in technology and markets. NDRC worksside-by-side with researchers, entrepreneurs and venture teams to turn great ideas into successful new ventures.By the end of 2014, NDRC’s portfolio of startup ventures had secured a cumulative €88m in follow-on investment from commercial investors, with a combined market capitalisation of approx. €220m.
Show more...Investment focus
- Industry: Software, Information Technology, E-Commerce
- Stage:Seed, Pre-Seed, Convertible Note
- Geography: Ireland, United States, United Kingdom
Investor stats
- Total investments: 107
- Round size: Seed $21k–$1.1M; Pre-Seed $32k–$145k; Convertible Note $107k–$250k
- Lead/follow: 69% lead, 31% follow
Portfolio highlights
- Hiiker — Find 1000s of the best backpacking and hiking adventures, with reviews, photos, and great places to stay.
- Legitify — Legitify is an AI powered solution using audio-video authentication that allows customers to notarize documents online remotely from anywhere, without the hassle of visiting a notary public in person.
- Dataships — Dataships uses top level data privacy software to help your brand, no matter your location.
Enterprise Equity (or EEVC) is an excellent for providing capital to early stage and expanding business throughout Ireland.
Show more...Investment focus
- Industry: Software, Information Technology, Medical Device
- Stage:Seed, Series B
- Geography: Ireland, United States, United Kingdom
Investor stats
- Total investments: 51
- Round size: Seed $536k–$2.1M; Series B $2.5M–$7.5M
- Lead/follow: 10% lead, 90% follow
Portfolio highlights
- Phorest — Join 8000+ spas, barbers, hair, beauty and nail salon owners using the #1 management, scheduling, POS and appointment booking system. Try Phorest now!
- SurgaColl — SurgaColl Technologies is a medical device company developing novel tissue regeneration products for the surgical treatment of diseases of the bone, cartilage and other human tissue. Based on technology developed at the Tissue Engineering Research Group (TERG) of the Royal College of Surgeons in Ireland (RCSI), headed by Professor Fergal O’Brien,the company aims to become a leader in the field of regenerative medical devices.
- Metabolomic Diagnostics — https://metabolomicdiagnostics.com/ A deep-tech company specialized in the development of biomarker-based diagnostic solutions
Technology-focused, investing capital and expertise to fuel growth in the most promising ideas and companies. Raised c.€600m across multiple funds and invest from seed to growth.We look for companies with potentially cutting-edge, category-defining businesses in markets including application software, IT infrastructure, communications, Internetand mobile. We help founders create and scale businesses globally. We work as a small team with diverse strengths accessing a community of over 200 founders. The teams and companies we back scale their investor base as they scale their business execution and ambition. We work closely with them in this process. Over the past 25 years have built a broad network of US and European investors and founders that share our vision and approach.Act is based in Dublin, Ireland.Our most recent funds are supported by the European Investment Fund.
Show more...Investment focus
- Industry: Software, Information Technology, Analytics
- Stage:Seed, Series A
- Geography: Ireland, United States, United Kingdom
Investor stats
- Total investments: 132
- Round size: Seed $804k–$3.3M; Series A $2.4M–$13M
- Lead/follow: 46% lead, 54% follow
- Last fund: Likely still investing — fund raised in 2022
Portfolio highlights
- Oblivious — Oblivious builds tools to allow you to use your sensitive data with internal and external partners while keeping it private and secure.
- Everyangle — Everyangle facilitates business in computer vision applications based on cisco meraki MV smart cameras across retail and industrial firms.
- Spectrum Life — Spectrum.Life's comprehensive solution enables organisations to provide a workplace wellbeing programme that can have a substantially positive impact on their health and wellness, as well as on the culture and performance of the company.
Irrus Investments is the leading Irish business angel network with international connections. Fueling Irish innovation in medical devices, software, hardware, digital healthcare and life sciences.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical Device
- Stage:Seed, Series A
- Geography: Ireland, Sweden, United States
Investor stats
- Total investments: 19
- Round size: Seed $696k–$3.8M
- Lead/follow: 21% lead, 79% follow
Portfolio highlights
- Ovagen — Ovagen is a biotechnology company that has developed the process of producing germ free (GF) chicken eggs and GF birds in commercial quantities for use primarily in the pharmaceutical industry. Ovagen can also provide a Contract Research Service and has extensive expertise in SPF poultry & rodent housing & husbandry, in specific poultry& rodent research technologies to GMP standards and in avian transgenics.
- ByoWave — ByoWave has developed the Proteus Controller, a modular, accessible video game controller for disabled and non-disabled gamers.
- Bluedrop Medical — Thermal and visual assessment in a single scan. Award winning, patented design.
Fountain Healthcare Partners is an Irish based life science venture capital fund. Fountain is exclusively focused on the life science sector. Specific areas of interest to them are: specialty pharma, medical devices, biotechnology and diagnostics. They will deploy the majority of their capital in Europe with a strong focus on Ireland.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Series B, Series C
- Geography: Ireland, United States, France
Investor stats
- Total investments: 40
- Round size: Series A $6.4M–$24M; Series B $5.4M–$48M; Series C $3.2M–$55M
- Lead/follow: 45% lead, 55% follow
- Last fund: May invest from a new fund soon — last raise in 2019
Portfolio highlights
- MMI — The future of Microsurgery: microinstruments that expand the possibilities of surgical interventions. Wristed robotic microinstruments for unprecedented results in microsurgery.
- Vivasure Medical — Medical device company developing a closure device for vascular access procedures.
- Ermium Therapeutics — Ermium Therapeutics is a biotech company developing innovative therapies for auto-immune diseases, based on a breakthrough discovery showing that CXCR4 is a master regulator of inflammation.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Elkstone Capital Partners is a multi-family office focused on venture, real estate and wealth management.
Show more...Investment focus
- Industry: Software, Medical, Medical Device
- Stage:Seed, Series A
- Geography: Ireland, United Kingdom, United States
Investor stats
- Total investments: 46
- Round size: Seed $536k–$2.8M; Series A $6.2M–$12M
- Lead/follow: 33% lead, 67% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- Mesh — The ONLY Email Security Platform purpose-built for MSPs with Best-In-Class Machine Learning Powered Detection, and a revolutionary centralized management console (MSP Hub)
- Manna Drone Delivery — Drone delivery made simple
- Bluedrop Medical — Thermal and visual assessment in a single scan. Award winning, patented design.
Early stage VC investments and funding for start-ups / founders in Ireland.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Series A
- Geography: Ireland, United States, United Kingdom
Investor stats
- Total investments: 96
- Round size: Seed $777k–$2.7M; Series A $1.6M–$6.4M
- Lead/follow: 29% lead, 71% follow
- Last fund: Likely still investing — fund raised in 2022
Portfolio highlights
- Kayna — Kayna is an insurance distribution company that collaborates with vertical SaaS platforms and utilises data to offer insurance services.
- Tailr — Redefining production for the clothing industry.
- Recruitroo — Recruitroo is a international recruitment agency that uses technologies to streamline and improve the international recruitment process for both companies and candidates.
EIT Health is a network of best-in-class health innovators backed by the EU. We deliver solutions to enable European citizens to live longer, healthier lives.
Show more...Investment focus
- Industry: Health Care, Medical Device, Medical
- Stage:Grant, Pre-Seed, Seed
- Geography: United Kingdom, Spain, Ireland
Investor stats
- Total investments: 90
- Round size: Seed $536k–$1.4M; Grant $21k–$1.2M; Pre-Seed $43k–$1.4M
- Lead/follow: 59% lead, 41% follow
Portfolio highlights
- Ochre Bio — Ochre Bio is developing therapies for the biggest liver health challenges.
- ZiO Health — ZiO Health develops multi-functional electronic devices for measuring, testing and detecting the molecular composition of chemical and biological substances for the presence, absence, or quantity of target molecules.
- Nanordica Medical — Nanordica Medical develops novel nanoparticle-based antibacterial wound care products.
Seroba is a leading European life sciences venture capital firm focused on value creation through backing winning biotech innovations.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Series B
- Geography: Ireland, United States, United Kingdom
Investor stats
- Total investments: 35
- Round size: Series A $1.2M–$24M; Series B $4.6M–$37M
- Lead/follow: 34% lead, 66% follow
- Last fund: May invest from a new fund soon — last raise in 2017
Portfolio highlights
- Perfuze — Perfuze was founded in 2018 by Wayne Allen and Liam Mullins. Perfuze is located within Galway City in the West of Ireland. The founders have over 30 years combined medtech experience within start-up and large corporations.Perfuze is developing innovative medical technology to treat acute ischemic stroke.Perfuze is developing innovative cathetertechnology to treat acute ischemic stroke. Their technology is intended to provide superior clinical outcomes in shorter procedural times; resulting in safe, cost-effective therapy. Perfuze was founded in 2018 by Wayne Allen and Liam Mullins. The founders have over 30 years combined medtech experience within start-up and large corporations. Perfuze is currently located in the Business Innovation Centre on the campus of the National University of Ireland, Galway, and is in the process of relocating to the IDA Business Park in Dangan, Galway.
- Sibylla Biotech — Sibylla Biotech developed small molecule folding interfering degraders (FIDs) that can address a range of therapeutic areas.
- Storm Therapeutics — Targeting pathways that modify RNA to deliver novel cancer therapeutics.
Business Venture Partners was founded in 2004 as a corporate finance adviser for SME/owner managed businesses. The investment team is comprised of Elliott Griffin, Ronan Smith, Edel Coen and Mark Ruane and the team skills combine deep industry knowledge with experience in venture investing, corporate finance and international expansion. Theteam works on behalf of its clients buying and selling companies, raising finances, working with start-ups and advising on strategic growth, business succession and owner exits.Since 2007, BVP has successfully raised and managed 10 Simple Green BES and EII Funds. They have invested, on behalf of their investors, in some of Ireland’s most innovative companies such as Celtic Bioenergy, EFT Controls, and UrbanVolt. Our investment strategy is to spread investments over project finance and a portfolio of high potential companies. Their philosophy is to work hard with each investment to deliver valuable support for the company promoters and build shareholder value for their investors.In 2016 BVP launched The 10th BVP Green EII Fund. The fund provides eligible investors with the opportunity to avail of up to 40% income tax relief and provides the investor access to a portfolio of cleantech companies and renewable energy projects. The 11th Green Fund will be launched in Q4 2017.
Show more...Investment focus
- Industry: Health Care, Information Technology, Software
- Stage:Seed, Series A
- Geography: Ireland, Luxembourg, The Netherlands
Investor stats
- Total investments: 20
- Round size: Seed $375k–$4.3M; Series A $2.4M–$12M
- Lead/follow: 38% lead, 62% follow
Portfolio highlights
- Chupi — Chupi is a multi award-winning fine jeweller making solid gold, diamond and precious gemstone jewellery in the heart of Dublin, Ireland.
- PlasmaBound — PlasmaBound provides a step-change technology, termed Controlled Plasma Ablation (CPA), which facilitates the structural adhesive joining of lightweight materials, namely carbon and glass fibre reinforced composites. CPA technology will accelerate the use of these lightweight composite materials into multi-material structural assemblies, byenabling reliable adhesive joining which is stronger than the composite structures themselves.
- Zeus Scooters — ZEUS is an Irish company deploying the World’s FIRST 3-wheeled electric scooter for the urban mobility sharing market. Our unique scooters with state-of-the-art technology and reliability that will ensure our users always enjoy the safest, smoothest and most stable ride.
Xenium Capital
Show more...Investment focus
- Industry: Medical Device, Health Care, Biotechnology
- Stage:Seed
- Geography: Ireland
Investor stats
- Total investments: 4
- Lead/follow: no public data
Portfolio highlights
- Atrian Medical — AtriAN is commercializing technology created at Mayo Clinic in the US. AtriAN is an Irish Medical Device company based in Galway--A powerful and prolific hub for medical devices.AtriAN uses a gentle energy, micro Pulsed Electric Fields (mPEF) to only ablate hyperactivity. The other tissues such as the myocardium are spared.
- ProVerum Medical — ProVerum Medical is an early stage medical device startup for the treatment of Benign Prostatic Hyperplasia (BPH).
- Tympany Medical — Tympany Medical is a Needs-driven, Innovative MedTech StartUp based in the West of Ireland
HBAN Medtech Syndicate
Show more...Investment focus
- Industry: Medical Device, Medical, Health Care
- Stage:Seed, Series B
- Geography: Ireland
Investor stats
- Total investments: 5
- Lead/follow: no public data
Portfolio highlights
- Deciphex — Deciphex - Transforming Digital Pathology - we are focussed on the development of applications for clinical and veterinary pathology that improve productivity
- Signum Surgical — Founded in 2014 by Eoin Bambury and Moshe Zilversmit, Signum Surgical is a medtech platform striving to develop technology that could cure perianal fistula. Bambury and Zilversmit, who met on the BioInnovate Ireland programme at NUI Galway, recognised a lack of innovation surrounding the treatment of perianal fistulas (small tunnels that developbetween the end of the bowel and the skin near the anus). The device developed by Signum Surgical is implanted post-surgery to prevent reinfection and to allow a faster healing process.
- Bluedrop Medical — Thermal and visual assessment in a single scan. Award winning, patented design.
Boole
Show more...Investment focus
- Industry: Medical Device, Health Care, Medical
- Stage:Seed
- Geography: Ireland
Investor stats
- Total investments: 4
- Lead/follow: no public data
Portfolio highlights
- Incereb — Lifelines Neuro offers exceptional infant EEG electrodes with Incereb. Learn more about this wonderful device for neonates in the NICU.
- ProVerum Medical — ProVerum Medical is an early stage medical device startup for the treatment of Benign Prostatic Hyperplasia (BPH).
Atlantic Bridge is a growth equity technology Fund with offices in Dublin, London, Palo Alto, Beijing, and Hong Kong. They focus on Middle Market Technology investments across Europe, with a strong emphasis on a transatlantic business building and investment exit model. We focus on making domain-specific investments in growth-stage companies,specifically in sectors such as Artificial Intelligence, Machine Learning, Robotics, Computer Visioning, IoT, Big Data, etc.Atlantic Bridge brings together a unique team of technology entrepreneurs, experienced managers, finance professionals, and investment experts. The team contains a wealth of international business experience across Europe, the US, and Asia. They have worked together in various capacities for the last 30 years, bringing a true partnership approach to their firm and their investments. Its investors include the founders, leading institutional investors, and private investors with a track record of investment in successful technology companies.Atlantic Bridge has developed a unique and differentiated strategy that focuses on specific technology themes and the implementation of the “Atlantic Bridge Model” for scaling companies internationally. The “Bridge Model” accelerates the scale-up of technology companies in the US and Chinese markets. This approach is highly differentiated and has delivered strong performance results to date.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Series A, Series B
- Geography: United States, Ireland, United Kingdom
Investor stats
- Total investments: 110
- Round size: Series A $5M–$25M; Series B $2.5M–$22M
- Lead/follow: 43% lead, 57% follow
- Last fund: May invest from a new fund soon — raised $86M in 2021
Portfolio highlights
- Mitiga — Mitiga proactively stores and enhances forensic data so our experts can start incident investigations fast to get you back to business as usual
- Oblivious — Oblivious builds tools to allow you to use your sensitive data with internal and external partners while keeping it private and secure.
- Bluedrop Medical — Thermal and visual assessment in a single scan. Award winning, patented design.
The Yield Lab Europe is a €50m early stage Agrifood and Ag Tech fund which comprises an accelerator and a larger follow-on fund, investing in high tech companies with the potential to significant disrupt and improve our current systems of global food production, and to improve the environmental sustainability of the industry. The main fund invests€1m each into 10-12 companies over several follow on rounds, with the strongest accelerator companies expected to progress to the main fund. The Yield Lab Europe is also part of a global network of Agrifood Tech funds, with global headquarters in St Louis USA, and sister funds in LATAM and Singapore.
Show more...Investment focus
- Industry: AgTech, Agriculture, Biotechnology
- Stage:Seed, Series A
- Geography: Ireland, United Kingdom, France
Investor stats
- Total investments: 27
- Round size: Seed $536k–$2M; Series A $3.8M–$10M
- Lead/follow: 19% lead, 81% follow
- Last fund: Likely still investing — raised $54M in 2021
Portfolio highlights
- Skytree — Transforming Carbon Removal for stable, reliable and sustainable CO2 supply
- BiOceanOr — BiOceanOr provides underwater weather stations to measure water quality. Their solutions provide informations from your exploitation in real-time. Receive alerts in real-time and take decisions with their preventive alert system.
- Solasta Bio — Solasta Bio develops environment-friendly products that meet a global need for new and effective crop protection.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!European Investment Bank (EIB) provides lending, borrowing, and treasury services primarily in the European Union.The company offers project loans for the public and private sectors; loans to banks and other intermediaries; structured finance products; guarantees and securitization instruments for senior and subordinated debts; project bonds;equity and fund investment products such as infrastructure equity and debt funds, and environmental funds; and venture capital funds and security packages for funds.The company also offers microfinance; risk sharing finance for research, development, and innovation projects; finance and technical expertise for sustainable energy projects; infrastructure project advisory services; support for urban development projects; guarantees for transport infrastructure; and funding for public-private partnerships and small- and medium-sized enterprises.EIB serves the transportation, global loans, energy, industry, health, education, water, sewerage, infrastructure, services, telecommunications, agriculture, and fisheries sectors.European Investment Bank was founded in 1958 and is based in Luxembourg.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Debt Financing, Post-IPO Debt
- Geography: France, Germany, Ireland
Investor stats
- Total investments: 202
- Round size: Post-IPO Debt $6.4M–$536M; Debt Financing $11M–$321M
- Lead/follow: 78% lead, 22% follow
Portfolio highlights
- Valmet — Valmet is the leading global developer and supplier of technologies, automation and services for the pulp, paper and energy industries.
- CTP — CTP NV is a real estate company that owns and develops industrial and logistics parks.
- Cofina Ivory — Cofina Ivory is a savings and credit institution that operates in the sector of mesofinance.
EQT life science develops innovative medicines, devices, and tools to address the single important thing that matters to the preservation of health. The organization believes that such opportunities add value to all stakeholders.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Series C
- Geography: United States, The Netherlands, Switzerland
Investor stats
- Total investments: 132
- Round size: Series A $6.4M–$50M; Series B $5.4M–$69M; Series C $10M–$70M
- Lead/follow: 36% lead, 64% follow
- Last fund: Likely still investing — raised $279M in 2023
Portfolio highlights
- VarmX — VarmX is a pharmaceutical spin-off from the Leiden University Medical Center. The mission of VarmX is to develop and manufacture therapeutic proteins to instantaneously restore blood clotting in bleeding patients. The lead product in the pipeline of VarmX is PseudoXa. PseudoXa is a modified recombinant human coagulation factor X which is capable ofimmediately restoring blood clotting in the presence of direct factor Xa anticoagulants (DOACS) such as rivaroxaban, apixaban, and edoxaban.These factor Xa coagulants are taken by millions of patients world-wide for the prevention and treatment of thrombosis and stroke, but as a side effect severe bleeding often occurs. PseudoXa is capable of stopping and preventing such bleedings thus making the usage of DOACS much safer.
- Xeltis — Xeltis is pioneering a restorative approach in cardiovascular therapy.
- Evommune — Evommune is taking a tissue-based approach to advance insights and accelerate the development of transformative medicines in inflammatory diseases.
Furthr VC invests in transformative tech. Furthr Venture Capital invests in scalable, early-stage companies. We help Ireland's next generation of technology.
Show more...Investment focus
- Industry: Medical, Medical Device, Health Care
- Stage:Seed, Pre-Seed
- Geography: Ireland
Investor stats
- Total investments: 12
- Round size: Seed $857k–$3.9M
- Lead/follow: 58% lead, 42% follow
- Last fund: May invest from a new fund soon — raised $34M in 2019
Portfolio highlights
- Klearcom — Klearcom tests the full customer call path from domestic phone number through the IVR Interactive Voice Response for connectivity and voice quality, validating voice call paths ensuring the connection between customer and agent is always reachable and accessible, software telecommunications IVR testing voice
- UrbanFox — UrbanFox protects online retailers against new forms of stealth fraud by analysing and learning from existing legitimate and fraudulent customer behavioural patterns.
- Bluedrop Medical — Thermal and visual assessment in a single scan. Award winning, patented design.
Broadview Ventures, Inc. (Broadview) was established in 2008 as a new program conceived by the Leducq family. Through Broadview, the trust will work to accelerate the development of promising technology in cardiovascular and neurovascular disease through targeted investment in and support of early stage technology ventures.The FoundationLeducq, based in Paris, France, is the beneficiary of a charitable trust. In order to further the Foundation Leducq's mission in cardiovascular and neurovascular disease, the trust has made funds available to Broadview to develop a program which will promote early state technology in these fields through investments, licensing agreements and consortium funding arrangements, as well as professional, management and consulting support.With this initiative the trust joins other leaders in the venture philanthropy movement in seeking creative solutions to the problem of what is commonly referred to as the 'translational gap', a significant component of which is a lack of funding at a critical moment in the development of new technology and science.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Series A, Seed, Debt Financing
- Geography: United States, Israel, Denmark
Investor stats
- Total investments: 66
- Round size: Seed $750k–$5.4M; Series A $1M–$11M; Debt Financing $1M–$2.4M
- Lead/follow: 24% lead, 76% follow
Portfolio highlights
- Nyra Medical — MitraPlug has created a catheter-plug technology for repairing a leaky mitral valve in the heart.This adjustable device needs only a two-inch surgical incision and can be inserted directly into the heart. Then the cardiologist can use the catheter to adjust the size and position of the plug to correct the leakage. When correctly fitted, thecatheter is removed, and the incision is closed, leaving only a small scar.
- RapidPulse — RapidPulse, Inc. is a privately held medical device company that develops minimally invasive vascular products for ischemic stroke. The company is advancing the development of the RapidPulse™ Cyclic Aspiration System, which includes a novel aspiration pump to allow rapid and consistent removal of blood clots from the brain. RapidPulse is a spinoutof Syntheon LLC., a medical device incubator dedicated to developing innovative products in the medical device industry
- Cardiosense — Cardiosense offers a physiological waveform AI platform to develop predictive biomarkers for the detection and treatment of disease. Its platform leverages multi-modal sensors and industry-leading AI to develop predictive biomarkers for the detection and treatment of disease.
Medtech Syndicate Nominee
Show more...Investment focus
- Industry: Medical, Health Care, Medical Device
- Stage:Seed, Series A
- Geography: Ireland
Investor stats
- Total investments: 3
- Lead/follow: no public data
Portfolio highlights
- Kite Medical — Kite medical has developed a novel device for detecting Kidney Reflux in children with Urinary Tract Infections. The non-invasive diagnostic solution for kidney reflux removes the need for complicated procedures and a hospital visit. Kidney reflux is the most common urological disorder in childhood, affecting up to three per cent of young children.It is most prevalent from six months to five years of age. The condition may resolve as the child gets older, but left undiagnosed and untreated it can lead to permanent kidney damage and ultimately to kidney failure.
- Signum Surgical — Founded in 2014 by Eoin Bambury and Moshe Zilversmit, Signum Surgical is a medtech platform striving to develop technology that could cure perianal fistula. Bambury and Zilversmit, who met on the BioInnovate Ireland programme at NUI Galway, recognised a lack of innovation surrounding the treatment of perianal fistulas (small tunnels that developbetween the end of the bowel and the skin near the anus). The device developed by Signum Surgical is implanted post-surgery to prevent reinfection and to allow a faster healing process.
BGF invests in hundreds of businesses from an evergreen balance sheet. But we offer more than just growth capital. Find out what makes us different.
Show more...Investment focus
- Industry: Software, Information Technology, Manufacturing
- Stage:Series A, Private Equity
- Geography: United Kingdom, Ireland, United States
Investor stats
- Total investments: 210
- Round size: Series A $1.2M–$16M; Private Equity $5.4M–$28M
- Lead/follow: 85% lead, 15% follow
- Last fund: Likely still investing — fund raised in 2022
Portfolio highlights
- Troy — Built on foundations of strong working relationships Troy is a vibrant and varied network of 212 distributors with 324 locations across the UK & Ireland.
- Archus — The healthcare infrastructure specialist. Bringing people together to deliver positive change and shape the future of healthcare.
- CHAIN Biotechnology — CHAIN Biotechnology is a microbiome therapeutics company with a novel drug development platform targeting chronic gut-related diseases. CHAIN is developing several therapeutic compounds targeted to the gut microbiome in the large intestine that can be delivered by our CADD technology.
VentureWave Capital is an actively managed private equity group that invests in and builds great companies.
Show more...Investment focus
- Industry: Health Care, Apps, Education
- Stage:Series A
- Geography: Ireland
Investor stats
- Total investments: 6
- Lead/follow: 83% lead, 17% follow
Portfolio highlights
- Xocean — Using unmanned surface vessels (USVs), XOCEAN offers turnkey data collection services to Surveyors, Companies and Agencies.
- Medihive — Our software and clinical solutions remove friction from patient pathways across healthcare, insurance, medtech and many more industries. Book a call today!
- Funderbeam — Funderbeam is a funding and trading platform that connects companies and investors to buy and sell equity stakes. The platform allows the founders to gain exposure, legal support, a funding manager, or an investor network. It also allows the investors to take control of their investments and trade anytime they want.The company was founded in 2013as a global data platform for startup companies.
Lightstone Ventures is a global venture capital firm that invests in personalized medicines and targeted therapeutics. Lightstone Ventures was founded in 2012 by the General Partners and other key members of the life science teams of Advanced Technology Ventures (ATV) and Morgenthaler. The firm was formed to capture the upside of investing inbreakthrough life science companies during a time of unique opportunity in space.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series B, Series A, Series C
- Geography: United States, Ireland, Singapore
Investor stats
- Total investments: 64
- Round size: Series A $5M–$95M; Series B $7.5M–$90M; Series C $20M–$73M
- Lead/follow: 27% lead, 73% follow
- Last fund: Likely still investing — fund raised in 2021
Portfolio highlights
- Nimbus Therapeutics — Nimbus Discovery is now Nimbus Therapeutics to reflect our transition into a clinical stage company. Nimbus Therapeutics is a biotechnology company headquartered in Cambridge, Mass., that is pioneering a new computational technology-driven paradigm to rapidly advance a diverse pipeline of novel small molecule product candidates into clinicaldevelopment. We are designing highly selective and potent medicines to disrupt known drivers of serious diseases, including metabolic disease, cancer and immune-inflammatory disorders.
- Relievant Medsystems — Relievant's mission is to provide patients with low risk therapy that can alleviate their back pain.
- Tagworks Pharmaceuticals — As pioneers of Click-to-Release technology, we are revolutionizing cancer treatment using in vivo click chemistry to increase the therapeutic window of powerful cancer therapies.
At Development Capital, they are aware of the significant growth opportunities available to mid-sized companies and understand the management teams’ unique requirement for not only finance, but also for a funding partner who will bring experience, expertise and international reach to assist secure and maximise the business growth opportunity.Development Capital provides investee companies with a unique and unprecedented partnership approach which will maximise the growth opportunity in the most prompt and efficient manner. In addition to their experienced Investment Directors, their partners include:High profile and experienced Industry Experts who will provide direction and support to investee companies; andMajor Irish Corporates who have committed not only funding but also their international experience.
Show more...Investment focus
- Industry: Manufacturing, Software, Health Care
- Stage:Seed
- Geography: Ireland, United States, United Kingdom
Investor stats
- Total investments: 14
- Lead/follow: 64% lead, 36% follow
- Last fund: May invest from a new fund soon — raised $80M in 2014
Portfolio highlights
- IP Telecom — Ireland's most competitive SME & Enterprise VoIP provider. We are Ireland's leading VoIP Phone Systems Provider. Connect your business to the technology of today.
- Nomadic Dairy — Nomadic Dairy is a growing, premium branded yogurt manufacturer. The company supplies multiple products across the UK and Republic of Ireland.
- Spotlight Oral Care — Spotlight Oral Care aims to create the best oral health products, to educate and promote oral care, empowering people to engage with true customised preventative oral care.
Founded in 1997, Earlybird invests in all development and growth phases of technology companies. Among the most experienced venture investors in Europe, Earlybird offers its portfolio companies not only financial resources but also strategic support plus access to an international network and capital markets. With EUR 2 billion under management,eight IPOs and 30 trade sales, Earlybird is one of the most established and active venture capital firms in Europe.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Series A, Seed, Series B
- Geography: Germany, United States, United Kingdom
Investor stats
- Total investments: 247
- Round size: Seed $1.2M–$14M; Series A $2M–$26M; Series B $4.8M–$40M
- Lead/follow: 47% lead, 53% follow
- Last fund: Likely still investing — fund raised in 2022
Portfolio highlights
- Binalyze — Binalyze enhances all your digital forensics and incident response processes at max speed.
- ColibrITD — Quantum Computing Software Algorithm
- Re-Fresh Global — Re-Fresh Global brings sustainability innovation into the manufacturing industry. Our patented biotechnology transforms textile waste into recycled raw materials: nanocellulose, ethanol, and sanitized textile pulp.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!HealthCap, a life science investor and company creator. Our motivation is to find innovative ideas and invest that could impact healthcare and society.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series B, Series A
- Geography: United States, Sweden, France
Investor stats
- Total investments: 109
- Round size: Series A $5.5M–$55M; Series B $20M–$54M
- Lead/follow: 25% lead, 75% follow
- Last fund: May invest from a new fund soon — last raise in 2019
Portfolio highlights
- Hemab — Hemab is pioneering the first preventative treatments and functional cures for patients with rare bleeding and thrombotic disorders.
- ADCendo — ADCendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs. We focus on antibody-drug conjugates (ADCs) directed at novel targets, that have been found to be overexpressed by several cancer forms, that are all characterized by a significant unmet need for novel treatment.
- Vicore Pharma — Vicore Pharma is a pharmaceutical company dedicated to developing innovative medicines for severe lung disorders. It develops drugs that act through the AT2 receptor. The company’s drug candidate C21 aims to improve the treatment of idiopathic pulmonary fibrosis, a rare disease for which C21 has been granted orphan drug designation both in the EUand the US. In addition, C21 is explored pre-clinically in a number of rare diseases where the AT2 receptor plays an important role. The company is based in Astra Zeneca’s Bioventurehub in Mölndal.
Cantor Fitzgerald is a global financial services firm that specializes in equities, investment banking, and real estate, fixed income and currencies, prime services, and, affiliates. The firm is known for developing advanced technologies to expand market access, and help clients achieve their most important financial and strategic objectives. Thiscommitment to client-centered innovation has led to enduring relationships with many of the world’s most demanding institutional investors and corporations. The company was founded in 1945 and is headquartered in New York.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Post-IPO Equity, Series B, Series A
- Geography: United States, Canada, Ireland
Investor stats
- Total investments: 12
- Round size: Series B $6.4M–$136M; Post-IPO Equity $12M–$250M
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- Wejo — We unlock limitless possibilities with connected vehicle data
- Satellogic — Making Earth Observation imagery accessible and affordable to solve the world's most pressing problems
- REIGO Investments — Reigo Investments is a technology company reshaping the real estate investment space. Focusing on the senior hard money lending US market, the company employs data science to improve performance, reduce defaults, and reduce underwriting time dramatically.
We work with leading corporations, startups, universities, and growers to solve the biggest challenges facing the agtech and foodtech industries.
Show more...Investment focus
- Industry: AgTech, Agriculture, Farming
- Stage:Pre-Seed, Seed
- Geography: United States, Canada, Ireland
Investor stats
- Total investments: 86
- Round size: Seed $100k–$6.3M; Pre-Seed $75k–$100k
- Lead/follow: 41% lead, 59% follow
- Last fund: Likely still investing — fund raised in 2022
Portfolio highlights
- FarmWise — FarmWise provides technology-based services that allow farmers to streamline farm operations and increase food production efficiency.
- Food4All — With the F4A App, you can explore discounted close-to-expiry products at your favourite supermarkets. Act now - save money and say no to food waste.
- Napigen — We are the genome editing company specialized for mitochondrial engineering. We address unmet needs of future food supplies by creating hybrid crop plants to boost their yields to an unprecedented level. The company’s technology creates robust male sterile lines that are ideal over conventional lines because of their stability and elitebackgrounds. This allows the production of non-GM hybrid seeds in crop plants that are currently mostly non-hybrid such as wheat. Our technology solution is expected to fulfill the highest level of public acceptance and aspiration.
Infinity Capital are hypothesis-driven investors - constantly calibrating ideas through a Silicon Valley/technology network that they've been building for over two decades. Their extensive technology and operating backgrounds, combined with over a dozen years each of successful startup investing, have been essential in buildingcredibility and a reputation that resonates with entrepreneurs.
Show more...Investment focus
- Industry: Semiconductor, E-Commerce, Electronics
- Stage:Series B, Series D
- Geography: United States, Ireland, Canada
Investor stats
- Total investments: 33
- Round size: Series B $9M–$50M; Series D $4M–$17M
- Lead/follow: 9% lead, 91% follow
- Last fund: May invest from a new fund soon — last raise in 2015
Portfolio highlights
- AltraTech — Next Generation Molecular Detection Discover Altratech Next Generation Molecular Detection Discover Altratech At Altratech, our mission is to enable next generation molecular detection.
- BioSapien — BioSapien is a pre-clinical biotech company developing novel biodegradable implantable products that deliver active pharmaceutical ingredients (APIs) for oncology indications with reduced systemic side effects. The applications for this technology are currently under investigation for pancreatic cancer and lung cancer. The intended pipeline ofindications is expected to expand into other cancers such as colorectal, breast, and stomach cancers. BioSapien's 3D-printed MediChip delivers FDA-approved toxic high-dose systemic therapies in a localized slow-release biodegradable mesh which is able to target tissues while improving patients' quality of care and life.
- Core Starters — Core Starters services startups and investors through blockchain-based decentralized services to solve real problems.
Mayo Clinic Ventures is dedicated to quickly bringing answers to the people who need them most: the patients living with diseases and conditions that threaten to limit or even end their lives. Our team works closely with Mayo physicians and scientists to mine inventions, ideas and discoveries that will truly transform health care. Their dedicatedefforts bring significant financial support to Mayo's patient care, education and research efforts.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Series B, Seed
- Geography: United States, Ireland, China
Investor stats
- Total investments: 35
- Round size: Seed $1.4M–$8.2M; Series A $5M–$26M; Series B $6.5M–$69M
- Lead/follow: 31% lead, 69% follow
- Last fund: May invest from a new fund soon — last raise in 2010
Portfolio highlights
- Turtle Health — Turtle Health is a virtual fertility counselling clinic. We provide you with personalized, medically meaningful information to help you plan your fertility journey, early and affordably.
- The Patient Company — The Patient Company provides clinical staff members with an automated lateral patient transfer device called SimPull. The company was founded in 2019 by Andrew Heuerman and is based in Grand Rapids, Michigan.
- Tympany Medical — Tympany Medical is a Needs-driven, Innovative MedTech StartUp based in the West of Ireland
Oyster Capital Partners, an Irish private equity firm, specializes in the energy technology, IT, and healthcare sectors.
Show more...Investment focus
- Industry: Software, Medical Device, Enterprise Software
- Stage:Series A, Seed
- Geography: Ireland, United Kingdom, United States
Investor stats
- Total investments: 18
- Round size: Series A $4M–$12M
- Lead/follow: 11% lead, 89% follow
Portfolio highlights
- Inclusio — The inclusio diversity and inclusion platform is designed to measure and positively shift the culture of your organisation. Contact us for more information.
- Ooodles — Ooodles is the smart way to get phones, laptops, gadgets and tech on a flexible, pay-as-you-go monthly rental. Free delivery, no upfront cost
- &Open — For businesses that gift to give back, share joy, or show they care. All you need is an email.
Discover start-up investing made simple. Access VC-led rounds, build your portfolio, and unlock growth at Ascentifi
Show more...Investment focus
- Industry: Medical Device, Medical, Hospital
- Stage:Series A
- Geography: Ireland
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- CroíValve — CroíValve is a developed a safe, effective, easy to use, percutaneous solution for treating all patients with severe Tricuspid Regurgitation
- Bluedrop Medical — Thermal and visual assessment in a single scan. Award winning, patented design.
E15 VC is a Hong Kong-based venture capital firm specializing in global deep-tech investments.
Show more...Investment focus
- Industry: Health Care, Medical, Robotics
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, Ireland
Investor stats
- Total investments: 8
- Round size: Seed $1.3M–$5M
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- Frankie Health — Frankie gets high-quality support to employees with a few clicks and without needing to tell anyone else about it. Frankie uses a proactive and personalised approach to mental healthcare with underlying predictive models. When employees are feeling strong, Frankie recommends proven exercises for building mental resilience. And when harder timescome, employees are guided to a selection of the highest quality therapists that are a good fit for them. Combining proven exercises for building resilience with professional support is core to Frankie’s personalised mental health journeys. Frankie uses end-to-end encryption for privacy and machine learning to improve effectiveness. Frankie integrates to the tools your team are already using such as Slack, Google and many more.
- Eikon Therapeutics — Eikon Therapeutics is a drug discovery and development company that leverages super-resolution microscopy as well as the latest advances in biology, chemistry, engineering, and automation toward the goal of discovering and inventing innovative therapies that will improve and extend life.
- Vicarious Surgical — Vicarious Surgical, a next-generation medical robotics company, designs technology for minimally invasive surgery with a focus on abdominal access and visualization through a single port.
Glanzmann Enterprises
Show more...Investment focus
- Industry: Medical, Health Care, Medical Device
- Stage:Series A
- Geography: Ireland
Investor stats
- Total investments: 2
- Lead/follow: no public data
Portfolio highlights
- Signum Surgical — Founded in 2014 by Eoin Bambury and Moshe Zilversmit, Signum Surgical is a medtech platform striving to develop technology that could cure perianal fistula. Bambury and Zilversmit, who met on the BioInnovate Ireland programme at NUI Galway, recognised a lack of innovation surrounding the treatment of perianal fistulas (small tunnels that developbetween the end of the bowel and the skin near the anus). The device developed by Signum Surgical is implanted post-surgery to prevent reinfection and to allow a faster healing process.
Venture capital and technology investments
Show more...Investment focus
- Industry: Software, E-Commerce, Internet
- Stage:Series A, Seed, Series B
- Geography: United States, United Kingdom, Germany
Investor stats
- Total investments: 597
- Round size: Seed $1.5M–$7M; Series A $3M–$20M; Series B $5M–$45M
- Lead/follow: 32% lead, 68% follow
- Last fund: Likely still investing — raised $378M in 2023
Portfolio highlights
- JOKR — Grocery shopping is easier now with JOKR, your instant delivery app. Order your groceries and favorite products in our online supermarket and get them instantly at your door. Download the app now and make your first grocery order on us. Available in IOs and Android. Access www.jokr.com for more info
- Vera — Vera develops an assessment platform to identify and address risks in artificial intelligence and machine learning models. It engages key stakeholders across teams to create data-driven assessments and use data science tools to investigate AI and ML models, helping organizations navigate through uncertainty and protecting companies and individualsfrom risky artificial intelligence systems.
- Nextdata — Nextdata offers an operating system for decentralized data at scale on an AI platform.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Furthr provides long-term support to startups and SME businesses in Ireland. We support Irish entrepreneurs who excel in innovation and international trading.
Show more...Investment focus
- Industry: Software, Internet, Data and Analytics
Investor stats
- Total investments: 5
- Lead/follow: 0% lead, 100% follow
- Last fund: May invest from a new fund soon — last raise in 2007
Cell Capital focuses on seed to series A investments, with a special concentration in the agrifood sector. Cell Capital is located in London, United Kingdom.
Show more...Investment focus
- Industry: Internet of Things, Software, Information Technology
- Stage:Seed
- Geography: United Kingdom, Ireland, United States
Investor stats
- Total investments: 4
- Lead/follow: 25% lead, 75% follow
Portfolio highlights
- QuestDB — QuestDB is an open source time-series database. The database is column-oriented and optimized for high-speed ingest and blazingly fast SQL analytics.
- CarbonChain — We automate your supply chain carbon accounting, so you can tackle climate risks, reduce emissions, and accelerate the transition to a net-zero economy.
- Micron AgriTech — Micron Agritech is home to the Micron Kit, and allows farmers and vets to test animals on site for parasites and get results within 30 minutes
Our invest in and partner with private and small capitalization biotech, specialty pharma and medical device companies.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Science/Engineering
- Stage:Post-IPO Equity
Investor stats
- Total investments: 10
- Round size: Post-IPO Equity $14M–$155M
- Lead/follow: 25% lead, 75% follow
- Last fund: May invest from a new fund soon — raised $200M in 2019
A design-led software company, a specialist in designing, building and operating scalable, secure cloud-native applications, with a venture capitalist twist.
Show more...Investment focus
- Industry: Software, IT, Data and Analytics
- Stage:Pre-Seed, Seed
Investor stats
- Total investments: 12
- Lead/follow: 8% lead, 92% follow
- Last fund: May invest from a new fund soon — last raise in 2018
DHKN has professionals in Audit, Accountancy, Corporate Finance, Tax Consultancy & Compliance, Outsourced Services and Corporate Governance & Compliance firm all under one roof in Galway.
Show more...Investment focus
- Industry: Medical, Health Care, Medical Device
- Geography: Ireland
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Versono Medical — Versono Medical is an early stage Irish MedTech company located in Galway. Our focus is on a new Medical Technology for Endovascular Surgery.
Moffett Investment Holdings is an investment firm
Show more...Investment focus
- Industry: Medical, Health Care, Biotechnology
- Stage:Series A, Series B
- Geography: Ireland
Investor stats
- Total investments: 2
- Lead/follow: no public data
Portfolio highlights
- Neuromod Devices — Neuromod is a medical device company formed to advance the science of bi-modal neuromodulation.We are committed to delivering treatments that significantly reduce the suffering of underserved patient populations who live with chronic and debilitating conditions globally. Our goal is to design products that empower patients to take control oftheir own treatment, delivering targeted therapies that integrate seamlessly into a modern lifestyle.Neuromod has developed and patented a bi-modal neuromodulation technology that it is evaluating for neurological disorders including chronic tinnitus, a condition affecting 10% of the adult population and commonly known as 'ringing in the ears'.
Welcome to The University of Vermont Health Network, five partner hospitals serving the residents of Vermont and northern New York. With over 4,000 health care providers throughout our region, they work together to offer high-quality care more cost-efficiently and as close to home as possible. Strengthened by their connection, each of theirhospitals remains committed to its local community and to the heart and science of medicine: compassionate, personal care shaped by the latest medical advances and delivered by highly skilled experts.
Show more...Investment focus
- Industry: Medical, Biotechnology, Fashion
- Stage:Seed, Series B
- Geography: United States, Ireland
Investor stats
- Total investments: 3
- Lead/follow: 67% lead, 33% follow
Portfolio highlights
- BioFactura — BioFactura has developed the StableFast™ Biomanufacturing Platform, a novel system to rapidly generate stable NS0 cell lines for biopharmaceutical manufacturing. The elements of this system include a chemically-defined, serum- and cholesterol-free production medium and pre-adapted parental cells, modular expression vectors that utilize a patentedselection strategy, and a proprietary growth supplement that permits rapid generation and cloning of cell lines. This platform is simple to use, fast, and productive. A clonal production cell line can be developed and scaled up to yield over one gram of product in less than eight weeks.
- THEYA Healthcare — Creators of the Post Surgery Bra proven to heal. Hypoallergenic and Antibacterial Underwear for Sensitive Skin, Post Partum, and Menopause using soft, safe & sustainable bamboo. Post-Op wear from labiaplasty recovery to stoma briefs. Mastectomy and breast cancer care specialists. Sizes XS to 4XL & Worldwide Shipping!
- Veralox Therapeutics — Veralox Therapeutics develops small molecule therapeutics that treat the underlying pathologies of thrombosis and type one diabetes. Based on an understanding of the molecular mechanisms of these diseases, these efforts will lead to new treatment paradigms and better outcomes for patients.
Gaingels is a venture investment syndicate in service of the LGBT+ community and its allies, investing in companies with LGBT+ founders and C-suite leaders at all stages of growth, as well as in more established companies resolved on building more inclusive teams, with a global portfolio of 130+ companies and $70M in deployed investment capital todate. The Gaingels network also actively supports its portfolio in identifying and recruiting diverse talent to their C-suite and board leadership teams and fosters a vibrant global community of industry leaders, investors, operators, and entrepreneurs who share a common goal for positive social change through business and successful investments.
Show more...Investment focus
- Industry: Software, Health Care, FinTech
- Stage:Seed, Series A, Series B
- Geography: United States, Canada, Germany
Investor stats
- Total investments: 464
- Round size: Seed $1.2M–$6M; Series A $4M–$50M; Series B $19M–$70M
- Lead/follow: 1% lead, 99% follow
- Last fund: Likely still investing — raised $1.1M in 2023
Portfolio highlights
- KittyCAD — Infrastructure for hardware design tools.
- Paxton AI — Regulatory Intelligence, with the speed of Generative AI.
- Atropos Health — Atropos Health rapidly provides personalized real-world evidence for any clinical decision
Gilde Healthcare is a specialized European healthcare investor managing two business lines: a lower mid-market buy-out fund and a venture & growth capital fund. It has over €800 million ($900 million) under management and is actively looking to lead new investments in digital health, diagnostics, medical devices, therapeutics and healthcareservices. Gilde successfully builds healthcare businesses across Europe and US, investing up to €35 million in a single portfolio company.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series C, Series B, Series A
- Geography: United States, The Netherlands, Germany
Investor stats
- Total investments: 100
- Round size: Series A $8.6M–$47M; Series B $8M–$60M; Series C $21M–$50M
- Lead/follow: 37% lead, 63% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- FIRE1 — FIRE1 and is based in Dublin, Ireland, will focus on developing novel therapeutic devices.
- ADCendo — ADCendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs. We focus on antibody-drug conjugates (ADCs) directed at novel targets, that have been found to be overexpressed by several cancer forms, that are all characterized by a significant unmet need for novel treatment.
- GT Medical Technologies — At GT Medical Technologies, our purpose is Improving the Lives of Patients with Brain Tumors. GammaTile Therapy is Surgically Targeted Radiation Therapy (STaRT) for patients with brain tumors.
Wellcome Trust is a medical research charity that funds research that aims to protect and improving human and animal health. It focuses on the fields of public engagement, investments, innovation, humanities, and social science. It was founded in 1936 and headquartered in London, England.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Pharmaceutical
- Stage:Grant, Series C
- Geography: United States, United Kingdom, Germany
Investor stats
- Total investments: 109
- Round size: Grant $1.2M–$6.8M; Series C $10M–$90M
- Lead/follow: 36% lead, 64% follow
- Last fund: May invest from a new fund soon — last raise in 2018
Portfolio highlights
- Vaxxas — Vaxxas develops and commercializes needle-free vaccine delivery system. Vaxxas was incorporated in 2011 and is based in Brisbane, Australia.
- DataDotOrg — data.org brings together philanthropy, technology, academia, and social impact organizations to build the field of data science for social impact.
- Feinstein Institute for Medical Research — Feinstein Institute For Medical Research is the research arm of Northwell Health, the largest health care provider and private employer in New York State. Home to 50 research labs, 3,000 clinical research studies and 5,000 researchers and staff, the Feinstein Institutes raises the standard of medical innovation through its five institutes ofbehavioral science, bioelectronic medicine, cancer, health innovations and outcomes, and molecular medicine. We make breakthroughs in genetics, oncology, brain research, mental health, autoimmunity, and are the global scientific leader in bioelectronic medicine – a new field of science that has the potential to revolutionize medicine.
Health Care VC funding in Ireland at a glance
Stats across 246 deals from 182 investors.
Access all 182 VC funds in Ireland Health Care startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Health Care VC Funds in Ireland investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 182 VC funds investing in Ireland Health Care startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!